Thus, because of the highly angiogenic phenotype of RCC and its dependence on HIF and HIF-regulated factors, we sought to assess the potential of using mCECs and CEPs as potential biomarkers of RCC in the VHL patient population and also in patients with sporadic RCC. This evidence concerns the gene VHL and renal cell carcinoma.